UAB Biotechnologinės farmacijos centras "Biotechpharma"
JAR Code: 300041719
ActiveFinancial Reports
| 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|
| Revenue | 76 153 418 | 123 919 188 | 93 045 600 | 74 035 286 | |
| Profit Before Tax | 34 384 439 | 60 120 244 | 50 779 570 | 45 581 203 | |
| Net Profit | 34 384 439 | 60 120 244 | 50 779 570 | 45 581 203 | |
| Profit margin | 45.2% | 48.5% | 54.6% | 61.6% | |
| Equity | 54 189 605 | 97 117 629 | 94 214 496 | 114 940 959 | |
| Liabilities | 67 622 662 | 58 745 860 | 61 164 150 | 61 271 818 | |
| Total Assets | 133 732 686 | 167 604 957 | 166 255 608 | 186 555 996 |
Financial Reports
2024
Balance Sheet
Total Assets186 555 996 €
Long-term Assets83 999 105 €
Short-term Assets102 556 891 €
Equity114 940 959 €
Liabilities61 271 818 €
Profit & Loss Statement
Revenue74 035 286 €
Profit Before Tax45 581 203 €
Net Profit45 581 203 €
2023
Balance Sheet
Total Assets166 255 608 €
Long-term Assets56 086 298 €
Short-term Assets110 169 310 €
Equity94 214 496 €
Liabilities61 164 150 €
Profit & Loss Statement
Revenue93 045 600 €
Profit Before Tax50 779 570 €
Net Profit50 779 570 €
2022
Balance Sheet
Total Assets167 604 957 €
Long-term Assets85 544 582 €
Short-term Assets82 060 375 €
Equity97 117 629 €
Liabilities58 745 860 €
Profit & Loss Statement
Revenue123 919 188 €
Profit Before Tax60 120 244 €
Net Profit60 120 244 €
2021
Balance Sheet
Total Assets133 732 686 €
Long-term Assets56 206 419 €
Short-term Assets77 526 267 €
Equity54 189 605 €
Liabilities67 622 662 €
Profit & Loss Statement
Revenue76 153 418 €
Profit Before Tax34 384 439 €
Net Profit34 384 439 €
2020
Balance Sheet
Total Assets77 681 954 €
Long-term Assets55 621 007 €
Short-term Assets22 060 947 €
Equity30 265 275 €
Liabilities36 658 151 €
Profit & Loss Statement
Revenue45 564 702 €
Profit Before Tax20 920 218 €
Net Profit20 920 218 €
2019
Balance Sheet
Total Assets42 554 890 €
Long-term Assets22 123 576 €
Short-term Assets20 431 314 €
Equity17 324 990 €
Liabilities12 401 820 €
Profit & Loss Statement
Revenue37 702 884 €
Profit Before Tax15 959 865 €
Net Profit15 959 865 €
2018
Balance Sheet
Total Assets35 706 162 €
Long-term Assets22 073 574 €
Short-term Assets13 632 588 €
Equity10 953 434 €
Liabilities13 231 576 €
Profit & Loss Statement
Revenue28 743 994 €
Profit Before Tax9 588 309 €
Net Profit9 588 309 €
2017
Balance Sheet
Total Assets30 434 322 €
Long-term Assets23 549 399 €
Short-term Assets6 884 923 €
Equity6 774 495 €
Liabilities15 042 604 €
Profit & Loss Statement
Revenue20 779 585 €
Profit Before Tax5 409 370 €
Net Profit5 409 370 €
2016
Balance Sheet
Total Assets36 522 215 €
Long-term Assets23 586 163 €
Short-term Assets12 936 052 €
Equity7 937 260 €
Liabilities19 815 009 €
Profit & Loss Statement
Revenue28 230 253 €
Profit Before Tax6 572 135 €
Net Profit6 572 135 €
2015
Balance Sheet
Total Assets26 246 550 €
Long-term Assets18 852 585 €
Short-term Assets7 393 965 €
Equity4 476 903 €
Liabilities11 978 808 €
Profit & Loss Statement
Revenue13 781 815 €
Profit Before Tax3 140 384 €
Net Profit3 140 384 €
2014
Balance Sheet
Total Assets20 316 655 €
Long-term Assets17 157 428 €
Short-term Assets3 159 227 €
Equity2 547 434 €
Liabilities7 974 714 €
Profit & Loss Statement
Revenue3 501 593 €
Profit Before Tax−86 494 €
Net Profit−86 494 €
Source: Registrų centras